BRTX vs MCO · rev $401.0K vs P/E 33, rev $7.72B
BioRestorative Therapies Inc (BRTX) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported MCO revenue for 2025-12-31 was $7.72B. Net income was $2.46B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
BRTX currently screens at market cap $10.2M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the BRTX and MCO stock pages for the full models.
Not investment advice.